Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $6.83M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Actinium Pharmaceuticals USD 6.83M 1.48M Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025